Evidence map›Paper›PMID 39188337›Full record

ArticleCureus2024

Nail Discoloration Following the Chronic Use of Skin-Depigmenting Creams.

Manuji Bandara, Achala Liyanage

Abstract readCase Reports
In one paragraph

Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Manuji BandaraInternal Medicine, University of Ruhuna, Galle, LKA.
Achala LiyanageDermatology, University of Ruhuna, Galle, LKA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Skin-depigmenting creams are on the rise, driven by societal pressures that equate fair skin with beauty, success, and happiness. This trend has led to many unregulated products being released on the market, causing various adverse effects on users. This case report examines five patients with nail hyperpigmentation following the use of skin-depigmenting creams containing hydroquinone (HQ). The findings from this case report showcase overlooked side effects of these widely used creams. Healthcare providers may be unfamiliar with the rare side effects of depigmenting creams, leading to misdiagnoses and unnecessary evaluations. Moreover, there is a pressing need for healthcare authorities to enhance regulation and for healthcare providers to be more vigilant in diagnosing presentations of nail hyperpigmentation. This case report provides valuable insights into the side effects of HQ-based creams as observed in the Asiatic population.

Indexed as

hydroquinonenail discolorationnail hyperpigmentationskin depigmenting agentskin lightening cream

Identifiers

PMID39188337
PMCPMC11345540

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.